July 17, 2013 — Hematopoietic stem cells -- bone marrow-derived adult stem cells that give rise to the wide variety of specialized blood cells -- come in two flavors: the reserve force sits quietly waiting to be called upon while the active arm continually proliferates spawning billions of blood cells every day. In their latest study, researchers at the Stowers Institute for Medical Research reveal a new mechanism that is critical in maintaining the delicate balance between the two.
This could make cdx-301 a blockbuster?
CDX-301: Clinical Program CLINICAL PROGRAM FOR TREATMENT OF CANCER PATIENTS REQUIRING HEMATOPOIETIC STEM CELL TRANSPLANTATION
weight no doubt CLDX will be a player in stem as it relates to 301...but this is why I like PSTI specifically as pure play stem provider....enjoy!
Positive Data From the First Study Prompts Decision
HAIFA, Israel, July 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, has recommended to Pluristem that NIAID expand the scope of its ongoing animal research using PLX-RAD cells for the treatment of acute radiation syndrome (ARS).
....ARS is a real UNMET need given the TERRORISTS pension to cause pain and suffering...the FEDS know that they are WEAK ON TERROR and BORDERS are like a sithe so we must prepare now for the next leg of our Self Inflicted Armageddon which could be some sort of Dirty Bomb attack! Many thousands will come down w/ ARS depending on where they strike...but rest assured it will be a populated City not Abandoned like Detroit but more like NYC unfortunately!
shes popping some today in PM as the Market sees what I know and share!